...
首页> 外文期刊>RSC Advances >Fabrication of mesoporous silica nanoparticles hybridised with fluorescent AIE-active quinoline-malononitrile for drug delivery and bioimaging
【24h】

Fabrication of mesoporous silica nanoparticles hybridised with fluorescent AIE-active quinoline-malononitrile for drug delivery and bioimaging

机译:与荧光AIE-活性喹啉-丙二腈杂交的介孔二氧化硅纳米粒子的制备,用于药物递送和生物成像

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A novel type of fluorescent mesoporous silica nanoparticle (FMSN) has been successfully synthesised by hybridising mesoporous silica nanospheres with an aggregation-induced emission luminogen, a quinoline-malononitrile derivative. The FMSNs with uniform morphology show excellent AIE-active luminescence and good biocompatibility. Transmission electron microscopy (TEM) demonstrates that the well-ordered mesoporous structure in FMSNs is beneficial for drug delivery. When loaded with doxorubicin (DOX), DOX@FMSNs demonstrate pH-dependent release character and high cytotoxicity towards MCF-7 cancer cells. These FMSNs are expected to be promising multifunctional candidates as both bioimaging agents and drug carriers in cancer therapy.
机译:通过将介孔二氧化硅纳米球与聚集体诱导的发光原(喹啉-丙二腈衍生物)杂交,成功地合成了新型荧光介孔二氧化硅纳米颗粒(FMSN)。具有均匀形态的FMSN显示出​​优异的AIE活性发光和良好的生物相容性。透射电子显微镜(TEM)证明FMSN中有序的介孔结构有利于药物输送。当装载阿霉素(DOX)时,DOX @ FMSNs表现出pH依赖的释放特性,并且对MCF-7癌细胞具有高细胞毒性。这些FMSN有望成为有前途的多功能候选物,成为癌症治疗中的生物成像剂和药物载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号